These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14116089)

  • 1. [USE OF A SYNTHETIC HEPARINOID IN LIPID METABOLISM DISORDERS. PRELIMINARY STUDY].
    RABY C; SAINT-BLANCARD J; PAGE G; BIED B; VIGNE J; OUGIER J
    Sem Ther; 1963 Dec; 39():658-64. PubMed ID: 14116089
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE SIGNIFICANCE OF INSUFFICIENT CLEARANCE IN ATHEROGENESIS].
    SCHOEN H
    Munch Med Wochenschr; 1963 Dec; 105():2473-8. PubMed ID: 14133657
    [No Abstract]   [Full Text] [Related]  

  • 3. [On oral treatment with heparin and heparinoids].
    HEYMANN W
    Bibl Haematol; 1963; 15():132-9. PubMed ID: 13954327
    [No Abstract]   [Full Text] [Related]  

  • 4. [LIPOLYTIC ACTIVITY OF SOME ANTI-ATHEROSCLEROTIC DRUGS].
    SCHOEN H; SAUER M
    Arzneimittelforschung; 1963 Aug; 13():718-22. PubMed ID: 14085927
    [No Abstract]   [Full Text] [Related]  

  • 5. [ON THE EFFECTIVENESS OF ANTIATHEROSCLEROTIC DRUGS].
    SCHOEN H; ZELLER W; DITTERICH S
    Med Klin; 1964 Jun; 59():939-43. PubMed ID: 14234234
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipoprotein-lipase modifications in subjects treated with a synthetic, heparin-like polyanion (SP 54).
    Frandoli G; Spreafico PL
    Farmaco Prat; 1972 Sep; 27(9):514-8. PubMed ID: 5074781
    [No Abstract]   [Full Text] [Related]  

  • 7. [STUDIES ON THE ACTION OF A SYNTHETIC HEPARINOID (FIBROCID) IN THE COAGULATION-ANTICOAGULATION PROCESS].
    SANCHEZFAYOS J; OUTEIRINO J; ALBORES I; PANIAGUA G
    Rev Clin Esp; 1964 Aug; 94():275-9. PubMed ID: 14208057
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperlipemia: clinico-therapeutic experience with a heparinoid].
    De Martino G; D'Aniello L; De Simone E; Belli MG; Buonfantino M
    Clin Ter; 1978 Sep; 86(6):583-95. PubMed ID: 83925
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the behavior of the plasma "clearing factor" after the administration of a synthetic heparinoid].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1498-9. PubMed ID: 13807122
    [No Abstract]   [Full Text] [Related]  

  • 10. [RESEARCH ON THE MECHANISM OF ACTION OF A NATURAL HEPARINOID. STUDY OF COAGULATION, FIBRINOLYSIS AND OF THE INTENSITY OF HEMORRHAGE].
    TURAZZA G; GIBELLI A; BISIANI M
    Gazz Int Med Chir; 1963 Dec; 67():2515-26. PubMed ID: 14164429
    [No Abstract]   [Full Text] [Related]  

  • 11. On the effect of alimentary lipemia and a natural heparinoid on the fibrinolytic system of man.
    KONTTINEN Y
    Scand J Clin Lab Invest; 1962; 14():87-99. PubMed ID: 14458289
    [No Abstract]   [Full Text] [Related]  

  • 12. [HEPARINOIDS--PHYSIOLOGICAL PROPERTIES AND THERAPEUTIC INDICATIONS].
    GUILLEMAN P; HARDY N
    Rev Prat; 1964 Oct; 14():3391-405. PubMed ID: 14205831
    [No Abstract]   [Full Text] [Related]  

  • 13. [ACTION OF DUODENAL HEPARINOID ON GLUCIDE METABOLISM].
    BARBEITOARANDA A; PRESS L; GIORDANO J; LOPEZGIL AL; CAMPAGNOLI M
    Dia Med; 1963 Sep; 35():1491-3. PubMed ID: 14089621
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of an extractive heparinoid on some blood coagulation indices].
    Guidi G; Lombardi V; Torsellini A
    Minerva Med; 1969 Dec; 60(99 Suppl):5034-8. PubMed ID: 4188587
    [No Abstract]   [Full Text] [Related]  

  • 15. [COMPARISON OF SOME EFFECTS OF HEPARIN AND THE PERORAL HEPARINOID "ATEROID" IN RATS].
    CEPELIK J; CERNOHORSKY M
    Cas Lek Cesk; 1963 Nov; 102():1291-4. PubMed ID: 14111755
    [No Abstract]   [Full Text] [Related]  

  • 16. [USE OF A SYNTHETIC HEPARINOID: CB 8061. CONSIDERATIONS ON 50 CASES AFTER 10 MONTHS OF CLINICAL AND BIOLOGICAL TRIALS].
    MANS J; GENES M
    J Med Bord; 1963 Dec; 140():1886-93. PubMed ID: 14099058
    [No Abstract]   [Full Text] [Related]  

  • 17. [RESEARCH ON THE FIBRINOLYTIC AND ANTICOAGULANT ACTION OF A SULFURATED DERIVATIVE OF XYLAN (SYNTHETIC HEPARINOID) WITH A LOW-GRADE POLYMERIZATION].
    CIPOLLI PL; GIBELLI A
    Riv Patol Clin; 1963 Aug; 18():395-403. PubMed ID: 14083551
    [No Abstract]   [Full Text] [Related]  

  • 18. [COMPARATIVE VALUE OF GENERAL AND LOCAL FACTORS IN THE ORIGIN OF ARTERIOSCLEROSIS].
    MOGA A
    Stud Cercet Endocrinol; 1963; 14():475-83. PubMed ID: 14102529
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of thrombogenesis in the pathogenesis of arteriosclerosis (literature review)].
    Zaĭtsev VF; Ananchenko VG
    Kardiologiia; 1967 Jan; 7(1):83-7. PubMed ID: 4882302
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trial of a synthetic heparinoid in the treatment of atherogenic dyslipemia].
    Broustet P; Dallocchio M; Crockett R; Bricaud H
    Gaz Med Fr; 1965 Oct; 72(20):3513-7. PubMed ID: 4159547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.